Lisa Ricciardi

CEO at CogRx

Ms. Ricciardi joined Cognition Therapeutics in March 2019 as a member of the Board of Directors and was appointed CEO in March 2020. She possesses a unique perspective and breadth of knowledge formed during a career working in multiple industry segments, including drug development and commercialization, healthcare services and genomics. She has a proven track record launching large-market therapeutics as well as negotiating financial and business development agreements, from small to multi-billion-dollar deals. Before her appointment as interim CEO, Ms. Ricciardi served as an advisor at M.M. Dillon, a boutique life-sciences investment bank, where she provided counsel to biotech companies on transactions with pharma and biopharma companies. Earlier, she was CEO of Suono Bio, a biotech company founded on technology licensed from MIT, which she led through a Series A fundraising. Ms. Ricciardi held senior business development positions at Foundation Medicine, where she negotiated the $1.03 billion transformational agreement with Roche in 2015, and at Medco, where she was involved in numerous deals including the $29 billion acquisition of Medco by Express Scripts in 2011. Earlier, Ms. Ricciardi held positions at Pfizer in commercial operations, in which role she was involved in growing the company’s cardiovascular, arthritis/rheumatology and anti-infectives franchises and was responsible for the launches of Norvasc, Zithromax and Trovan. She transitioned from commercial operations to global licensing and development in 2004. As SVP of this division, she completed numerous global R&D and commercial collaborations for assets in various stages of development. In addition to her role at Cognition Therapeutics, Ms. Ricciardi is a member of the Board of Directors of United Drug Healthcare Group, a Dublin-based pharmaceutical outsourced supplier. In this role, she serves on the Compensation, Risk/Investment and Audit Committees. Previous director roles include Sepracor (acquired by Dainippon), Chimerix and Contrafect. Ms. Ricciardi earned a Bachelor of Arts cum laude in English and religion from Wesleyan University and a Master of Business Administration from the University of Chicago Booth School of Management.
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.